HIMS WS

Hims & Hers Health, Inc.

A telehealth company that lets people consult with licensed doctors online and get prescriptions for sensitive health issues—hair loss, erectile dysfunction, weight management, mental health, and skincare—delivered discreetly to their door. Founded in 2017 inside the San Francisco venture studio Atomic Labs, it launched as "Hims" to destigmatize men's health topics, then added the "Hers" brand a year later for women's care, giving the company its playful pronoun-based name. Today it serves both men and women through a subscription platform where members message providers around the clock.

WARRANTUnderlying: HIMSCUSIP: 433000114HealthcareUS1 holder

Class A Common Stock

Ownership Activity Financials Filings

Insiders

Ranked by how much each holding moved in the last 3 years

Insider

Dudum AndrewChief Executive Officer, Director, 10% owner · 230 transactions

22.89M—

Granted 6.97M · Sold 7.14M

Bard AlexDirector · 4 transactions

5.23M—

as of Jun 2024

Granted 27.1K

Baird MelissaChief Operating Officer · 144 transactions

817.8K+91.6%

as of May 2025

Granted 1.52M · Sold 965.7K

Chi MichaelChief Operating Officer · 142 transactions

432.1K+153.8%

Granted 2.52M · Sold 1.54M

Boughton SoleilChief Legal Officer · 94 transactions

341.6K+103.2%

Granted 1.31M · Sold 746.6K

Okupe OluyemiChief Financial Officer · 161 transactions

292.2K—

Granted 2.48M · Sold 1.49M

Wells David BDirector · 13 transactions

229.0K-40.7%

Granted 94.5K · Bought 48.4K · Sold 300.0K

Carroll Patrick HarrisonChief Medical Officer · 35 transactions

181.9K+19.8%

Granted 265.0K · Sold 176.8K

O'Keefe Lynne ChouDirector · 7 transactions

177.6K+12.5%

as of Jun 2024

Granted 49.8K · Sold 30.1K

Payne Christopher DDirector · 6 transactions

144.3K—

Granted 34.3K · Bought 110.0K

Elshenawy MohamedCTO · 3 transactions

101.0K—

Granted 282.6K · Sold 30.0K

Bhattacharyya AmbarDirector · 2 transactions

91.0K+46.4%

as of Jun 2024

Granted 28.8K

Perez Garcia Andrea GDirector · 5 transactions

83.8K+90.9%

Granted 42.4K · Sold 2.5K

Cosgrove Delos M.Director · 5 transactions

68.0K+102.6%

Granted 34.4K

Autor Deborah M.Chief Policy Officer, Director · 8 transactions

64.4K—

Granted 82.7K · Sold 7.1K

Pendarvis ChristianeDirector · 9 transactions

55.4K—

Granted 78.9K · Sold 23.5K

Manuel AnjaDirector · 6 transactions

38.7K—

Granted 33.7K · Bought 5.0K

Schultz KareDirector · 3 transactions

19.4K—

Granted 19.4K

Becklund IrenePAO · 65 transactions

6.8K+147.2%

Granted 266.2K · Sold 165.2K

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Dudum AndrewChief Executive Officer, Director, 10% owner · 230 transactions	—	22.89M	6.97M	—	7.14M
Bard AlexDirector · 4 transactions	—	5.23Mas of Jun 2024	27.1K	—	—
Baird MelissaChief Operating Officer · 144 transactions	+91.6%	817.8Kas of May 2025	1.52M	—	965.7K
Chi MichaelChief Operating Officer · 142 transactions	+153.8%	432.1K	2.52M	—	1.54M
Boughton SoleilChief Legal Officer · 94 transactions	+103.2%	341.6K	1.31M	—	746.6K
Okupe OluyemiChief Financial Officer · 161 transactions	—	292.2K	2.48M	—	1.49M
Wells David BDirector · 13 transactions	-40.7%	229.0K	94.5K	48.4K	300.0K
Carroll Patrick HarrisonChief Medical Officer · 35 transactions	+19.8%	181.9K	265.0K	—	176.8K
O'Keefe Lynne ChouDirector · 7 transactions	+12.5%	177.6Kas of Jun 2024	49.8K	—	30.1K
Payne Christopher DDirector · 6 transactions	—	144.3K	34.3K	110.0K	—
Elshenawy MohamedCTO · 3 transactions	—	101.0K	282.6K	—	30.0K
Bhattacharyya AmbarDirector · 2 transactions	+46.4%	91.0Kas of Jun 2024	28.8K	—	—
Perez Garcia Andrea GDirector · 5 transactions	+90.9%	83.8K	42.4K	—	2.5K
Cosgrove Delos M.Director · 5 transactions	+102.6%	68.0K	34.4K	—	—
Autor Deborah M.Chief Policy Officer, Director · 8 transactions	—	64.4K	82.7K	—	7.1K
Pendarvis ChristianeDirector · 9 transactions	—	55.4K	78.9K	—	23.5K
Manuel AnjaDirector · 6 transactions	—	38.7K	33.7K	5.0K	—
Schultz KareDirector · 3 transactions	—	19.4K	19.4K	—	—
Becklund IrenePAO · 65 transactions	+147.2%	6.8K	266.2K	—	165.2K

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.